Clinical trials: Their design, location, and, potentially, their simulation

Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.

‘Pharmaceutical pipeline enhancement strategies’ being the full description behind the company’s name, Dr Li explains how Phesi operates, providing as it does comprehensive clinical development analytical products and services for global biopharma.

Dr Li also discusses the complications of relocating site to other regions and countries, including the wider impact of geopolitical events on clinical development, and explains the role AI-driven solutions can play in drug development, in terms of patient profiling, trial simulation, protocol design, and digital control arms. The conversation also touches upon Phesi’s work within the oncological space.

You can listen to episode 131a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, acast, Stitcher, and Podbean.